& Catalano, D
Since its discovery in 1977, DSIP has transitioned from being viewed strictly as a somnogenic (sleep-inducing) agent to a multifaceted neuromodulator with significant implications in neuroendocrinology and stress adaptation
As a drug, it was originally used to help cancer patients deal with the side-effects of chemotherapy
Garai S, Bhowal B, Kaur C, Singla-Pareek SL, Sopory SK (2021) What signals the glyoxalase pathway in plants
You want to ensure that every supplement you take is actually serving a purpose and, more importantly, that they are working together rather than competing for absorption
Association of tumor necrosis factor alpha, interleukin 6, and C-reactive protein with the risk of developing Type 2 diabetes: A retrospective cohort study of rural Thais